Altered iron metabolism as a target for ferroptosis induction in head and neck cancer

被引:0
作者
Jaewang Lee
Jong-Lyel Roh
机构
[1] CHA Bundang Medical Center,Department of Otorhinolaryngology
[2] CHA University,Head and Neck Surgery
[3] CHA University,Department of Biomedical Science, General Graduate School
来源
Cellular Oncology | 2023年 / 46卷
关键词
Iron; Labile iron pool; Ferroptosis; Regulators; Head and neck cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Iron is a mineral micronutrient essential for survival and vital functions in many biological processes in living organisms. Iron plays a crucial role as a cofactor of iron-sulfur clusters in energy metabolism and biosynthesis by binding with enzymes and transferring electrons to targets. Iron can also impair cellular functions by damaging organelles and nucleic acids by producing free radicals from redox cycling. Iron-catalyzed reaction products can induce active-site mutations in tumorigenesis and cancer progression. However, the boosted pro-oxidant iron form may contribute to cytotoxicity by increasing soluble radicals and highly reactive oxygen species via the Fenton reaction. An increased redox-active labile iron pool is required for tumor growth and metastasis, but the increased cytotoxic lipid radicals also lead to regulated cell death, such as ferroptosis. Therefore, this may be a major target for selectively killing cancer cells. This review intends to understand altered iron metabolism in cancers and discuss iron-related molecular regulators highly associated with iron-induced cytotoxic radical production and ferroptosis induction, focusing on head and neck cancer.
引用
收藏
页码:801 / 810
页数:9
相关论文
共 50 条
[41]   Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer [J].
Knecht, R. .
HNO, 2009, 57 (05) :436-+
[42]   STAT3 as a therapeutic target in head and neck cancer [J].
Leeman, RJ ;
Lui, VWY ;
Grandis, JR .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (03) :231-241
[43]   Induction chemotherapy before surgery for unresectable head and neck cancer [J].
Schmaltz, H. ;
Borel, C. ;
Ciftci, S. ;
Takeda-Raguin, C. ;
Debry, C. ;
Schultz, P. ;
Dupret-Bories, A. .
B-ENT, 2016, 12 (01) :29-32
[44]   Induction chemotherapy in head and neck cancer: are we too ambitious? [J].
Specenier, Pol .
FUTURE ONCOLOGY, 2014, 10 (03) :337-340
[45]   Induction mechanism of ferroptosis: A novel therapeutic target in lung disease [J].
Pan, Lingyu ;
Gong, Chunxia ;
Sun, Yehong ;
Jiang, Yeke ;
Duan, Xianchun ;
Han, Yanquan ;
Wang, Yongzhong .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[46]   Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment [J].
Yang, Jing ;
Gu, Zhaowei .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[47]   Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers [J].
Hsieh, Pei-Ling ;
Chao, Shih-Chi ;
Chu, Pei-Ming ;
Yu, Cheng-Chia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
[48]   Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments [J].
Li, Shuang ;
Liu, Yan ;
Li, Jinqiu ;
Zhao, Xue ;
Yu, Dan .
DNA AND CELL BIOLOGY, 2021, 40 (06) :720-732
[49]   Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer [J].
Wang, Hong-Tao ;
Ju, Jie ;
Wang, Shao-Cong ;
Zhang, Yu-Hui ;
Liu, Cui-Yun ;
Wang, Tao ;
Yu, Xue ;
Wang, Fei ;
Cheng, Xue-Ru ;
Wang, Kun ;
Chen, Zhao-Yang .
FRONTIERS IN ONCOLOGY, 2022, 12
[50]   Ferroptosis: An Emerging Target for Bladder Cancer Therapy [J].
Shan, Zhengda ;
Tang, Wenbin ;
Shi, Zhiyuan ;
Shan, Tao .
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (10) :8201-8214